These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 32247028)

  • 1. A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Recognitions from the finding of autoantibodies against ß2-adrenergic receptors.
    Wirth K; Scheibenbogen C
    Autoimmun Rev; 2020 Jun; 19(6):102527. PubMed ID: 32247028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME.
    Scheibenbogen C; Loebel M; Freitag H; Krueger A; Bauer S; Antelmann M; Doehner W; Scherbakov N; Heidecke H; Reinke P; Volk HD; Grabowski P
    PLoS One; 2018; 13(3):e0193672. PubMed ID: 29543914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of skeletal muscle disturbances in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Wirth KJ; Scheibenbogen C
    J Transl Med; 2021 Apr; 19(1):162. PubMed ID: 33882940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delineating the Association Between Soluble CD26 and Autoantibodies Against G-Protein Coupled Receptors, Immunological and Cardiovascular Parameters Identifies Distinct Patterns in Post-Infectious vs. Non-Infection-Triggered Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Szklarski M; Freitag H; Lorenz S; Becker SC; Sotzny F; Bauer S; Hartwig J; Heidecke H; Wittke K; Kedor C; Hanitsch LG; Grabowski P; Sepúlveda N; Scheibenbogen C
    Front Immunol; 2021; 12():644548. PubMed ID: 33889154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - Evidence for an autoimmune disease.
    Sotzny F; Blanco J; Capelli E; Castro-Marrero J; Steiner S; Murovska M; Scheibenbogen C;
    Autoimmun Rev; 2018 Jun; 17(6):601-609. PubMed ID: 29635081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.
    Bested AC; Marshall LM
    Rev Environ Health; 2015; 30(4):223-49. PubMed ID: 26613325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myalgic encephalomyelitis, chronic fatigue syndrome: An infectious disease.
    Underhill RA
    Med Hypotheses; 2015 Dec; 85(6):765-73. PubMed ID: 26604026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered Structural Brain Networks Related to Adrenergic/Muscarinic Receptor Autoantibodies in Chronic Fatigue Syndrome.
    Fujii H; Sato W; Kimura Y; Matsuda H; Ota M; Maikusa N; Suzuki F; Amano K; Shin I; Yamamura T; Mori H; Sato N
    J Neuroimaging; 2020 Nov; 30(6):822-827. PubMed ID: 32609410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics.
    Morris G; Maes M
    BMC Med; 2013 Sep; 11():205. PubMed ID: 24229326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A targeted genome association study examining transient receptor potential ion channels, acetylcholine receptors, and adrenergic receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
    Johnston S; Staines D; Klein A; Marshall-Gradisnik S
    BMC Med Genet; 2016 Nov; 17(1):79. PubMed ID: 27835969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgM-mediated autoimmune responses directed against anchorage epitopes are greater in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) than in major depression.
    Maes M; Mihaylova I; Kubera M; Leunis JC; Twisk FN; Geffard M
    Metab Brain Dis; 2012 Dec; 27(4):415-23. PubMed ID: 22614823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis/chronic fatigue syndrome.
    Gravelsina S; Vilmane A; Svirskis S; Rasa-Dzelzkaleja S; Nora-Krukle Z; Vecvagare K; Krumina A; Leineman I; Shoenfeld Y; Murovska M
    Front Immunol; 2022; 13():928945. PubMed ID: 36300129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).
    Hardcastle SL; Brenu EW; Johnston S; Nguyen T; Huth T; Wong N; Ramos S; Staines D; Marshall-Gradisnik S
    BMC Immunol; 2015 Jun; 16():35. PubMed ID: 26032326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation.
    Maes M; Ringel K; Kubera M; Anderson G; Morris G; Galecki P; Geffard M
    J Affect Disord; 2013 Sep; 150(2):223-30. PubMed ID: 23664637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single nucleotide polymorphisms and genotypes of transient receptor potential ion channel and acetylcholine receptor genes from isolated B lymphocytes in myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Marshall-Gradisnik S; Johnston S; Chacko A; Nguyen T; Smith P; Staines D
    J Int Med Res; 2016 Dec; 44(6):1381-1394. PubMed ID: 27834303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naltrexone Restores Impaired Transient Receptor Potential Melastatin 3 Ion Channel Function in Natural Killer Cells From Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
    Cabanas H; Muraki K; Staines D; Marshall-Gradisnik S
    Front Immunol; 2019; 10():2545. PubMed ID: 31736966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunopathogenesis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)].
    Yamamura T; Ono H; Sato W
    Brain Nerve; 2018 Jan; 70(1):35-40. PubMed ID: 29348373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmunity's enigmatic role: exploring the connection with myalgic encephalomyelitis/chronic fatigue syndrome.
    Batham J; Dwyer J; Eaton-Fitch N; Marshall-Gradisnik S
    BMC Immunol; 2024 Oct; 25(1):62. PubMed ID: 39354352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
    Maes M; Twisk FN; Ringel K
    Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveying the Metabolic and Dysfunctional Profiles of T Cells and NK Cells in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Maya J
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.